Arcutis Biotherapeutics Inc (ARQT) Transcripts
Q2 2024 Arcutis Biotherapeutics Inc Earnings Call Transcript
Aug 14, 2024
$9.58
(-3.72%)
Earnings
Q1 2024 Arcutis Biotherapeutics Inc Earnings Call Transcript
May 14, 2024
$8.13
(+1.75%)
Earnings
Q4 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
Feb 27, 2024
$10.63
(+9.70%)
Earnings
Arcutis Biotherapeutics Inc ZORYVE (roflumilast) Foam Launch Call Transcript
Jan 22, 2024
Q3 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
Nov 03, 2023
$2.44
(+9.91%)
Earnings
Arcutis Biotherapeutics Inc Provides Positive Atopic Dermatitis Program Updates Call Transcript
Sep 19, 2023
Arcutis Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 12, 2023
Q2 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
Aug 08, 2023
$9.83
(+2.61%)
Earnings
Arcutis Biotherapeutics Inc at Goldman Sachs Healthcare Conference Transcript
Jun 13, 2023
Q1 2023 Arcutis Biotherapeutics Inc Earnings Call Transcript
May 09, 2023
$14.82
(+3.93%)
Earnings
Arcutis Biotherapeutics Inc at Needham Healthcare Conference (Virtual) Transcript
Apr 18, 2023
Q4 2022 Arcutis Biotherapeutics Inc Earnings Call Transcript
Feb 28, 2023
$16.18
(+1.25%)
Earnings
Arcutis Biotherapeutics Inc Atopic Dermatitis Topline Data Call Transcript
Dec 12, 2022
Q3 2022 Arcutis Biotherapeutics Inc Earnings Call Transcript
Nov 08, 2022
$18.7
(+1.03%)
Earnings
Arcutis Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference Transcript
Sep 13, 2022
Arcutis Biotherapeutics Inc FDA Approval Conference Call Transcript
Aug 01, 2022
Arcutis Biotherapeutics Inc Topline Data Call Transcript
Jun 06, 2022
Arcutis Biotherapeutics Inc Corporate Analyst Meeting Transcript
Mar 28, 2022
Arcutis Biotherapeutics Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript
Sep 15, 2021
Arcutis Biotherapeutics Inc DERMIS-1/DERMIS-2 Phase 3 Plaque Psoriasis Topline Data Review - Conference Call Transcript
Feb 01, 2021
Arcutis Biotherapeutics to Discuss Positive Topline Data from Phase 2b Study of ARQ-154 - Conference Call Transcript
Nov 23, 2020
Arcutis Biotherapeutics Inc Announces Positive Topline Data from Phase 2 Seborrheic Dermatitis- Corporate Call Transcript
Sep 29, 2020
Arcutis Biotherapeutics Inc at Cantor Fitzgerald Global Healthcare Conference (Virtual) Transcript
Sep 17, 2020
Arcutis Biotherapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) Transcript
Jun 11, 2020